Abstract:Background Damage to the coronary arteries during the acute phase of Kawasaki disease (KD) is linked to inflammatory cell infiltration, myointimal proliferation, and endothelial cell (EC) dysfunction. To understand the response of ECs to KD treatment, we studied the genome‐wide transcriptional changes in cultured ECs incubated with KD sera before and after treatment with or without atorvastatin. Methods and Results RNA sequencing of human umbilical vein ECs incubated with pooled sera from patients with acute KD before or after treatment with intravenous immunoglobulin and infliximab revealed differentially expressed genes in interleukin‐1, tumor necrosis factor‐α, and inflammatory cell recruitment pathways. Subacute sera pooled from patients treated with intravenous immunoglobulin, infliximab, and atorvastatin uniquely induced expression of NOS3 , Kruppel like factor ( KLF2 , and KLF4 (promotes EC homeostasis and angiogenesis) and ZFP36 ring finger protein (ZFP36) and suppressor of cytokine signaling 3 (SOCS3) (suppresses inflammation), and suppressed expression of TGFB2 and DKK1 (induces endothelial‐mesenchymal transition) and sphingosine kinase 1 (SPHK1) and C‐X‐C motif chemokine ligand 8 (CXCL8) (induces inflammation). Conclusions These results suggest that atorvastatin treatment of patients with acute KD may improve EC health, reduce mediators of inflammation produced by ECs, and block KD‐induced myofibroblast proliferation. Nonstandard Abbreviations and Acronyms CA coronary artery DEG differentially expressed gene EC endothelial cell EndMT endothelial‐to‐mesenchymal transition HUVEC human umbilical vein endothelial cell KD Kawasaki disease NOS NO synthase RT‐PCR reverse transcriptase–polymerase chain reaction TGF‐β transforming growth factor‐β Clinical Perspective What Is New? Analyzing the gene expression profile of cultured endothelial cells incubated with sera from patients who received different treatments provides a window into the vascular effects of those treatments. Endothelial cells incubated with serum from patients with acute Kawasaki disease treated with standard therapy plus atorvastatin showed gene expression profiles with improved endothelial cell health and decreased inflammation compared with controls. What Are the Clinical Implications? Although the American Heart Association guidelines encourage adjunctive therapy for patients with acute Kawasaki disease with early echocardiographic signs of coronary artery damage, there are currently no clinical trial data to guide best practice to stop the progression of arterial wall damage and prevent coronary artery aneurysm formation during the acute phase of Kawasaki disease. We demonstrated deleterious changes in endothelial cell transcriptional profiles that were mitigated by exposure to sera from patients treated with atorvastatin. The anti‐inflammatory and endothelial‐protective effects of atorvastatin may yield benefit in blocking coronary artery aneurysm progression in patients with Kawasaki disease when added to standard therapy. Acute systemic inflammation associated with Kawasaki disease (KD) induces coronary artery (CA) aneurysms in a subset of genetically susceptible children. Early in the acute phase of this vasculitis, neutrophils adhere to activated endothelial cells (ECs) and enter the arterial wall. 1 Cytotoxic T cells follow and mediate further arterial damage, resulting in focal weakening and aneurysm formation. 2 Endothelial‐to‐mesenchymal transition (EndMT), a process that transforms ECs into myofibroblasts, can result in remodeling of the arterial wall with myointimal proliferation and stenosis of the arterial lumen. 3 , 4 Stenoses commonly occur at the inlet or outlet of the an -Abstract Truncated-

RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease

The Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease.

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease

Changes in CD_(69),CD_(25) and HLA-DR Expressions in Peripheral Blood T Cells in Kawasaki Disease

The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease

The role of Ca 2+ /NFAT in Dysfunction and Inflammation of Human Coronary Endothelial Cells induced by Sera from patients with Kawasaki disease

Monocyte‐Derived Interleukin‐1β As the Driver of S100A12‐Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease

VEGF subtype A and B Gene Expression, Clues to a Temporal Signature in Kawasaki Disease, Implications for Coronary Pathogenesis through a Secondary analysis of Clinical Datasets.

Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like Vasculitis Mouse Model

Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis

Inhibition of IL-1 Ameliorates Cardiac Dysfunction and Arrhythmias in a Murine Model of Kawasaki Disease

Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease

Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis

Adeno-associated Virus Vector-mediated Interleukin-10 Induction Prevents Vascular Inflammation in a Murine Model of Kawasaki Disease

KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease

Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis

Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis

Statin suppresses the development of excessive intimal proliferation in a Kawasaki disease mouse model

Assessment of vascular and endothelial function in Kawasaki disease

Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients